Stagg, B.C.; Uehara, H.; Lambert, N.; Rai, R.; Gupta, I.; Radmall, B.; Bates, T.; Ambati, B.K.
Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth. Cancers 2014, 6, 2330-2342.
https://doi.org/10.3390/cancers6042330
AMA Style
Stagg BC, Uehara H, Lambert N, Rai R, Gupta I, Radmall B, Bates T, Ambati BK.
Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth. Cancers. 2014; 6(4):2330-2342.
https://doi.org/10.3390/cancers6042330
Chicago/Turabian Style
Stagg, Brian C., Hironori Uehara, Nathan Lambert, Ruju Rai, Isha Gupta, Bryce Radmall, Taylor Bates, and Balamurali K. Ambati.
2014. "Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth" Cancers 6, no. 4: 2330-2342.
https://doi.org/10.3390/cancers6042330
APA Style
Stagg, B. C., Uehara, H., Lambert, N., Rai, R., Gupta, I., Radmall, B., Bates, T., & Ambati, B. K.
(2014). Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth. Cancers, 6(4), 2330-2342.
https://doi.org/10.3390/cancers6042330